Your browser doesn't support javascript.
loading
EWI2 promotes endolysosome-mediated turnover of growth factor receptors and integrins to suppress lung cancer.
Wang, Jie; Wren, Jonathan D; Ding, Yingjun; Chen, Junxiong; Mittal, Nikhil; Xu, Chao; Li, Xing; Zeng, Cengxi; Wang, Meng; Shi, Jing; Zhang, Yanhui H; Han, Sangyoon J; Zhang, Xin A.
Afiliação
  • Wang J; University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
  • Wren JD; Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.
  • Ding Y; University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
  • Chen J; University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
  • Mittal N; Michigan Technological University, Houghton, MI, USA.
  • Xu C; University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
  • Li X; Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
  • Zeng C; Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
  • Wang M; Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
  • Shi J; Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
  • Zhang YH; University of Tennessee Health Sciences Center, Memphis, TN, USA.
  • Han SJ; Michigan Technological University, Houghton, MI, USA.
  • Zhang XA; University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. Electronic address: xin-zhang-1@ouhsc.edu.
Cancer Lett ; 536: 215641, 2022 06 28.
Article em En | MEDLINE | ID: mdl-35339615
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antígenos CD / Adenocarcinoma de Pulmão / Neoplasias Pulmonares / Proteínas de Membrana Tipo de estudo: Prognostic_studies Limite: Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antígenos CD / Adenocarcinoma de Pulmão / Neoplasias Pulmonares / Proteínas de Membrana Tipo de estudo: Prognostic_studies Limite: Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article